GL1X · GenesisL1 explorer

Research workbench

Human ppargamma ligand-binding domain R288A mutant in complex with imatinib

Analyse Human ppargamma ligand-binding domain R288A mutant in complex with imatinib in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6KTN
Type
protein
Length
275 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Peroxisome proliferator-activated receptor gamma; 16-mer peptide from nuclear receptor…
EC
2.3.1.48
UniProt
P37231, Q15788
Ligands
STI
Pockets
2 · best druggability 0.84

Structure

x-ray diffraction · 2 distinct chains · 66% helix, 4% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
APeroxisome proliferator-activated receptor gammaprotein26466% helix, 5% strandP37231
B16-mer peptide from nuclear receptor coactivator 1 (EC 2.3.1.48)protein1173% helix, 0% strandQ15788

Ligands and binding sites

  • STI · 4-(4-methyl-piperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15190.840.9055STI
2510.300.7612empty

Interfaces

1 interface between chains.

  • A–B · 639 Ų buried · 10 hydrogen bonds · protein-protein

Compared structures

  • 6KTN · Human PPARgamma ligand-binding domain R288A mutant in complex with imatinib · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.